Marie‐Claude Morice

Active 1994–2025

Also published as
Marie-Claude Morice · Marie Claude Morice
190
Papers
52,066
Citations
102
h-index
188
i10-index

Citations

Citations per year for Marie‐Claude Morice1991: 1 citations1994: 1 citations1995: 1 citations1996: 22 citations1997: 25 citations1998: 64 citations1999: 25 citations2000: 40 citations2001: 61 citations2002: 81 citations2003: 180 citations2004: 207 citations2005: 231 citations2006: 199 citations2007: 204 citations2008: 213 citations2009: 216 citations2010: 257 citations2011: 310 citations2012: 277 citations2013: 390 citations2014: 353 citations2015: 258 citations2016: 298 citations2017: 257 citations2018: 315 citations2019: 836 citations2020: 963 citations2021: 908 citations2022: 756 citations2023: 570 citations2024: 898 citations2025: 350 citations2026: 21 citations1992–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,533 citing papers, 19% of this breakdownItaly: 1,031 citing papers, 7.8% of this breakdownUnited Kingdom: 1,015 citing papers, 7.6% of this breakdownGermany: 881 citing papers, 6.6% of this breakdownNetherlands: 793 citing papers, 6% of this breakdownFrance: 656 citing papers, 4.9% of this breakdownChina: 595 citing papers, 4.5% of this breakdownCanada: 563 citing papers, 4.2% of this breakdownJapan: 462 citing papers, 3.5% of this breakdownSwitzerland: 441 citing papers, 3.3% of this breakdownSpain: 424 citing papers, 3.2% of this breakdownBelgium: 325 citing papers, 2.4% of this breakdown
0%19%Other 27%

Fields

  • Medicine91.2%
  • Biochemistry, Genetics and Molecular Biology3.6%
  • Engineering1.8%
  • Materials Science1.1%
  • Immunology and Microbiology0.4%
  • Economics, Econometrics and Finance0.3%
  • Other1.6%

Topics

  • Coronary Interventions and Diagnostics16.7%
  • Cardiac Imaging and Diagnostics9.3%
  • Acute Myocardial Infarction Research8.9%
  • Antiplatelet Therapy and Cardiovascular Diseases5.4%
  • Cardiac Valve Diseases and Treatments5.1%
  • Cardiac and Coronary Surgery Techniques3.4%
  • Other51.2%

Coauthors

All papers

Open in search
  1. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease

    Authors: , , , , , , , , , , , , , - New England Journal of Medicine 2009 cited by 4,337

  2. Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 cited by 544

  3. Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ute Windhoevel, Robert W. Yeh, Mitchell W. Krucoff, Marie-Claude Morice - Circulation 2019 cited by 796

  4. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.

    Authors: , , , , , , , , , , - 2005 cited by 2,255

  5. Cyclosporine before PCI in Patients with Acute Myocardial Infarction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martine Gilard, Christophe Piot, Patrice Colin, F. De Poli, Marie‐Claude Morice, Omar Ider, Jean‐Luc Dubois‐Randé, Thierry Unterseeh, Hervé Breton, T Béard, Didier Blanchard, Gilles Grollier, V. Malquarti, Patrick Staat, Arnaud Sudre, Eskil Elmér, Magnus J. Hansson, Cyrille Bergerot, Inesse Boussaha, Claire Jossan, Geneviève Dérumeaux, Nathan Mewton, Michel Ovize - New England Journal of Medicine 2015 cited by 680

  6. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ute Windhoevel, Robert W. Yeh, Mitchell W. Krucoff, Marie-Claude Morice - European Heart Journal 2019 cited by 572

  7. Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philippe Gabríel Steg, Robert F. Storey, Jurriën M. ten Berg, Marco Valgimigli, Pascal Vranckx, Hirotoshi Watanabe, Stephan Windecker, Patrick W. Serruys, Robert W. Yeh, Marie‐Claude Morice, Dominick J. Angiolillo - Circulation 2023 cited by 165

  8. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael J. Mack, Tamás Szerafin, John K. Buckner, Myles S. Guber, Niels Verberkmoes, Ferdi Akca, Ted Feldman, Friedhelm Beyersdorf, Benny Drieghe, Keith G. Oldroyd, Geoff Berg, Anders Jeppsson, Kimberly Barber, Kevin Wolschleger, John Heiser, Pim van der Harst, Massimo A. Mariani, Hermann Reichenspurner, Christoffer Stark, Mika Laine, Paul C. Ho, John C. Chen, Richard Zelman, Phillip A. Horwitz, Andrzej Bochenek, Agata Krauze, Christina Grothusen, Dariusz Dudek, George P. Heyrich, Piroze Davierwala, Thilo Noack, Philippe Kolh, Victor Legrand, Pedro Coelho, Stephan Ensminger, Boris Nasseri, Richard Ingemansson, Göran Olivecrona, Javier Escaned, Reddy Guera, Sérgio Berti, Marie‐Claude Morice, Alaide Chieffo, M. Nicholas Burke, Michael Mooney, Alvise Spolaor, Christian Hagl, Michael Näbauer, Maarten J. Suttorp, Ronald A. Stine, Thomas McGarry, Scott Lucas, Knut Endresen, Andrew Taussig, Kevin Accola, Umberto Canosi, Iván Horváth, Louis Cannon, John D. Talbott, C W Akins, Robert S. Kramer, Michael Aschermann, William A. Killinger, Inga Narbute, David R. Holmes, Francesco Burzotta, Ad J.J.C. Bogers, Felix Zijlstra, Hélène Eltchaninoff, Jacques Berland and 26 more - The Lancet 2019 cited by 638

  9. ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - JACC: Cardiovascular Interventions 2021 cited by 239

  10. Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Roxana Mehran, Ioanna Kosmidou, Philippe Généreux, Aaron Crowley, Ovidiu Dressler, Patrick W. Serruys - New England Journal of Medicine 2019 cited by 785

  11. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Roxana Mehran, Stuart Pocock, A. Pieter Kappetein - New England Journal of Medicine 2016 cited by 1,055

  12. Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2016 cited by 438

  13. Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 cited by 808

  14. The European bifurcation club Left Main Coronary Stent study: a randomized comparison of stepwise provisional vs. systematic dual stenting strategies (EBC MAIN)

    Authors: , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2021 cited by 227

  15. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial

    Authors: , , , , , , , , , , , , - The Lancet 2013 cited by 1,785

  16. Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ernest Spitzer - Circulation 2022 cited by 74

  17. ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Arno W. Hoes, Juhani Knuuti, Philippe Kolh, Theresa A. McDonagh, Bruno Moulin, D. Poldermans, Bogdan A. Popescu, Željko Reiner, Udo Sechtem, Per Anton Sirnes, Adam Torbicki, Alec Vahanian, Stephan Windecker, Document Reviewers, Helmut Baumgartner, Christi Deaton, Carlos Aguíar, Nawwar Al‐Attar, Ángeles García, Anna Antoniou, Ioan Mircea Coman, Uri Elkayam, M. A. Gomez-Sanchez, Nina Gotcheva, Denise Hilfiker‐Kleiner, Róbert Gábor Kiss, Anastasia Kitsiou, Karen Konings, Gregory Y.H. Lip, Athanasios Manolis, A. Mebaaza, Iveta Mintāle, Marie-Claude Morice, B. J. M. Mulder, Agnès Pasquet, Susanna Price, S. G. Priori, M. J. Salvador, A. Shotan, Candice Silversides, Sven O. Skouby, J.-I. Stein, P. Tornos, Niels Vejlstrup, Fiona Walker, Carole A. Warnes - European Heart Journal 2011 cited by 1,923

  18. Revisiting Sex Equality With Transcatheter Aortic Valve Replacement Outcomes

    Authors: , , , , , , , , , , , , , - Journal of the American College of Cardiology 2015 cited by 239

  19. Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients

    Authors: , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2020 cited by 217

  20. A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization

    Authors: , , , , , , , , , , , - New England Journal of Medicine 2002 cited by 4,031

  21. Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial

    Authors: , , , , , , , , , , , , , , , , , , , , - The Lancet 2017 cited by 390

  22. Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial

    Authors: , , , , , , - American Heart Journal 2023 cited by 65

  23. Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2021 cited by 77

  24. Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2016 cited by 200